What is the Seoul Pharma Co., Ltd. stock price forecast?

Seoul Pharma Co., Ltd. is currently trading at ₩2,275. View real-time AI analysis on Alpha Lenz.

What is Seoul Pharma Co., Ltd. insider trading activity?

View the latest insider trading data for Seoul Pharma Co., Ltd. on Alpha Lenz.

What is Seoul Pharma Co., Ltd.'s P/E ratio?

Seoul Pharma Co., Ltd.'s P/E ratio is 35.2.

Seoul Pharma Co., Ltd.

KRX · 018680

₩2,275+40(+1.79%)Market closed

Ask about Seoul Pharma Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Seoul Pharma Co., Ltd. trades at a P/E of 35.2 (premium valuation) with modest ROE of 1.9%.”

Ask for details →

Company Overview

Seoul Pharma Co., Ltd. is a prominent player in the pharmaceutical industry, renowned for its focus on the research, development, and distribution of diverse pharmaceutical products. The company's portfolio includes prescription medications and over-the-counter drugs, addressing a wide range of therapeutic needs. Seoul Pharma operates in both domestic and international markets, continuously expanding its reach through innovative collaborations and strategic partnerships. The firm's commitment to enhancing healthcare outcomes drives its research initiatives, resulting in innovative solutions and effective treatments. As a part of the healthcare sector, Seoul Pharma plays a crucial role in advancing medical therapies and providing essential healthcare services to improve patient care and well-being in global communities.

CEO윤동현, 신봉환 (각자대표)

Websitehttps://www.seoulpharma.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees230

Company Statistics

FY 2025

Profile

₩26,524,950,725Market Cap

₩52,149,309,120Revenue

11.66MShares Out

230Employees

Margins

60.41%Gross

7.87%EBITDA

-2.45%Operating

1.21%Pre-Tax

1.45%Net

Valuation

35.20P/E

0.65P/B

0.51EV/Sales

8.28EV/EBITDA

26.74P/FCF

Growth (CAGR)

1.37%Rev 3Yr

-0.03%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

-4.12%Net Inc 3Yr

N/ANet Inc 5Yr

Returns

1.05%ROA

1.86%ROE

1.69%ROIC

Financial Health

₩9,948,545,830Cash & Cash Equivalents

₩20,755,979,780Net Debt

74.80%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Seoul Pharma Co., Ltd. trades at a P/E of 35.2 (premium valuation) with modest ROE of 1.9%.”

Ask for details →

Frequently Asked Questions

Seoul Pharma Co., Ltd. (ticker: 018680) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 230 employees. Market cap is $26.5B.

The current price is ₩2,275 with a P/E ratio of 35.2x and P/B of 0.65x.

ROE is 1.86% and operating margin is -2.45%. Annual revenue is $52.1B.